India, July 14 -- Today's top gainers in the biotech space include NextCure, ahead of its planned merger with a private company that will create a newly branded public entity; Basel Medical, which recently regained Nasdaq compliance; and Outlook Therapeutics, which is awaiting an FDA decision expected by the end of the month, among others.
Read on...
What is NXTC's next step?
NextCure Inc. (NXTC) was the top-performing stock on Tuesday, with shares soaring more than 200% on news of the company entering into a definitive merger agreement with Avere Therapeutics, Inc., a privately held biotechnology company, for an all-stock transaction.
The transaction is expected to close in the second half of 2026, and the combined company is expected ...